Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intraprostatic Fiducial Markers For Targeting of External Beam Radiation Therapy

NCT00499421 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00499421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00499421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intraprostatic Fiducial Markers For Targeting of External Beam Radiation Therapy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
September 14, 2005
Completion date
January 26, 2023
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer